Milestone Scientific, Inc. (MLSS): Price and Financial Metrics

Milestone Scientific, Inc. (MLSS): $0.69

0.02 (-2.29%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

MLSS Price/Volume Stats

Current price $0.69 52-week high $1.35
Prev. close $0.70 52-week low $0.52
Day low $0.67 Volume 75,200
Day high $0.76 Avg. volume 78,043
50-day MA $0.66 Dividend yield N/A
200-day MA $0.86 Market Cap 48.85M

MLSS Stock Price Chart Interactive Chart >

MLSS Stock Summary

  • MLSS has a higher market value than just 14.45% of US stocks; more precisely, its current market capitalization is $49,733,769.
  • The ratio of debt to operating expenses for MILESTONE SCIENTIFIC INC is higher than it is for about just 7.6% of US stocks.
  • With a year-over-year growth in debt of -18.87%, MILESTONE SCIENTIFIC INC's debt growth rate surpasses merely 17.2% of about US stocks.
  • If you're looking for stocks that are quantitatively similar to MILESTONE SCIENTIFIC INC, a group of peers worth examining would be HNST, ZOM, SIBN, CDXC, and SPWR.
  • Visit MLSS's SEC page to see the company's official filings. To visit the company's web site, go to www.milestonescientific.com.

MLSS Valuation Summary

  • MLSS's price/earnings ratio is -7; this is 124.01% lower than that of the median Healthcare stock.
  • Over the past 243 months, MLSS's price/sales ratio has gone down 1.2.

Below are key valuation metrics over time for MLSS.

Stock Date P/S P/B P/E EV/EBIT
MLSS 2023-12-29 5.0 6.8 -7.0 -6.7
MLSS 2023-12-28 4.8 6.4 -6.7 -6.4
MLSS 2023-12-27 4.6 6.2 -6.4 -6.1
MLSS 2023-12-26 4.3 5.8 -6.0 -5.7
MLSS 2023-12-22 4.3 5.8 -6.1 -5.7
MLSS 2023-12-21 4.3 5.8 -6.0 -5.7

MLSS Growth Metrics

    Its 5 year cash and equivalents growth rate is now at -73.96%.
  • Its 5 year net income to common stockholders growth rate is now at -50.8%.
  • Its year over year revenue growth rate is now at 53.89%.
Over the past 33 months, MLSS's revenue has gone up $1,036,501.

The table below shows MLSS's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 9.411002 -3.221857 -7.85378
2022-06-30 9.303536 -4.135996 -7.925184
2022-03-31 10.08091 -4.557275 -7.747171
2021-12-31 10.30471 -4.017581 -6.818317
2021-09-30 9.670744 -6.376852 -6.776149
2021-06-30 8.808621 -6.556074 -6.223931

MLSS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • MLSS has a Quality Grade of C, ranking ahead of 36.73% of graded US stocks.
  • MLSS's asset turnover comes in at 0.423 -- ranking 112th of 186 Medical Equipment stocks.
  • TNDM, TFX, and PEN are the stocks whose asset turnover ratios are most correlated with MLSS.

The table below shows MLSS's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.423 0.616 -2.177
2021-03-31 0.315 0.637 -2.538
2020-12-31 0.325 0.666 -3.651
2020-09-30 0.411 0.683 -7.765
2020-06-30 0.616 0.698 30.088
2020-03-31 1.274 0.690 6.927

Milestone Scientific, Inc. (MLSS) Company Bio


Milestone Scientific Inc. operates as a medical technology company. The Company manufactures, markets, and sells computer-controlled local anesthetic delivery systems for plastic surgery, podiatry, dermatology, and orthopedics. Milestone Scientific serves medical sector worldwide.


MLSS Latest News Stream


Event/Time News Detail
Loading, please wait...

MLSS Latest Social Stream


Loading social stream, please wait...

View Full MLSS Social Stream

Latest MLSS News From Around the Web

Below are the latest news stories about MILESTONE SCIENTIFIC INC that investors may wish to consider to help them evaluate MLSS as an investment opportunity.

Milestone Scientific Inc. Announces Closing of $3.0 Million Public Offering of Common Stock

ROSELAND, N.J., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the closing of its previously announced underwritten public offering of 4,765,000 shares of its common stock at a public offering price of $0.63 per share (the “Offering”). Gross proceeds before deducting underwriting discounts, commissions and other Offering expenses were approximately

Yahoo | December 13, 2023

Milestone Scientific Inc. Announces Pricing of $3.0 Million Public Offering of Common Stock

ROSELAND, N.J., Dec. 10, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the pricing of an underwritten public offering of 4,765,000 shares of its common stock at a price of $0.63 per share (the “Offering”). Gross proceeds before underwriting discounts and commissions and estimated Offering expenses are expected to be approximately $3.0 million. The Offering

Yahoo | December 11, 2023

Milestone Scientific announces proposed public offering of common stock

More on Milestone Scientific

Milestone Scientific Inc. Announces Proposed Public Offering of Common Stock

ROSELAND, N.J., Dec. 08, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has commenced an underwritten public offering of shares of its common stock (the “Offering”). The Company also expects to grant to the underwriters a 45-day option to purchase up to an additional 15% of the shares of common stock offered in the Offering on the same terms and con

Yahoo | December 8, 2023

Milestone Scientific Commences Sales of CompuFlo®  Disposables for Use in Neurostimulation Spinal Cord Implantation Procedures

Adoption of the technology at UTMB Health Clear Lake Campus Hospital follows successful evaluation process in these procedures—reporting 100% success CompuFlo helps minimize intraoperative cerebral fluid leakageand trauma to underlying nerve roots ROSELAND, N.J., Dec. 08, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today reported it has commenced commercial sales of Com

Yahoo | December 8, 2023

Read More 'MLSS' Stories Here

MLSS Price Returns

1-mo 1.47%
3-mo 14.85%
6-mo -29.23%
1-year -22.99%
3-year -82.96%
5-year 81.10%
YTD 0.01%
2023 43.73%
2022 -76.70%
2021 -2.83%
2020 52.52%
2019 318.67%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!